Inhibitory Effects of HangAmDan-B1 (HAD-B1) Combined With Afatinib on H1975 Lung Cancer Cell–Bearing Mice

Epidermal growth factor receptor mutation-positive non–small cell lung cancer is cared for mainly by target therapeutics in the clinical treatment at present. We investigated the antitumor effect of HangAmDan-B1 (HAD-B1) combined with afatinib on H1975 (L858R/T790M double mutation) lung cancer cells...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Integr Cancer Ther
Autors principals: Kang, Hwa Jeong, Kim, Jeehye, Cho, Seong Hyeok, Park, So-Jung, Yoo, Hwa-Seung, Kang, In-Cheol
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6419252/
https://ncbi.nlm.nih.gov/pubmed/30866688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1534735419830765
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars